Milton Boyer
President
As president of OSO BioPharmaceuticals Manufacturing, LLC, Milton Boyer is responsible for building an injectable drug contract manufacturing organization that distinguishes itself with world-class customer service.
Mr. Boyer has been responsible for guiding business strategies and creating new growth opportunities at OsoBio since 2008, most recently as vice president of business development and sales. He serves on OsoBio's board of directors.
With more than 20 years of professional experience within fine chemical and pharmaceutical business development, Boyer has developed special expertise in active pharmaceutical ingredients (APIs) and narcotic raw materials. He previously served as director of sales and marketing for Siegfried-USA and Chattem Chemicals Inc.. Mr. Boyer is currently serving a term as board member of Drugs, Chemicals & Allied Trades (DCAT), and is a member of other professional organizations, including Synthetic Organic Chemical Manufacturers Association (SOCMA) and the Generic Pharmaceutical Association (GPHA).